Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
Jacek Rysz, Anna Gluba-Brzózka, Magdalena Rysz-Górzyńska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 601-601
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

The oxidative status in patients with chronic kidney disease
V. Vasylchenko, L. Korol, О. Б. Кучменко, et al.
The Ukrainian Biochemical Journal (2020) Vol. 92, Iss. 5, pp. 70-77
Open Access | Times Cited: 15
Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial
Naba Al‐Sari, Signe Schmidt, Tommi Suvitaival, et al.
Endocrinology Diabetes & Metabolism (2021) Vol. 4, Iss. 2
Open Access | Times Cited: 13
Clusters of Physical Frailty and Cognitive Impairment and Their Associated Comorbidities in Older Primary Care Patients
Sanja Bekić, František Babič, Viera Pavlišková, et al.
Healthcare (2021) Vol. 9, Iss. 7, pp. 891-891
Open Access | Times Cited: 13
Apolipoprotein A-I Supports MSCs Survival under Stress Conditions
Светлана Мирошниченко, И. Ф. Усынин, А. Н. Дударев, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4062-4062
Open Access | Times Cited: 13
Network-Based Approach and IVI Methodologies, a Combined Data Investigation Identified Probable Key Genes in Cardiovascular Disease and Chronic Kidney Disease
Mohd Murshad Ahmed, Safia Tazyeen, Shafiul Haque, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 8
Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
Satyendra Kumar Sonkar, Prashant Singh, Sharad Chandra, et al.
Brazilian Journal of Nephrology (2022) Vol. 44, Iss. 3, pp. 329-335
Open Access | Times Cited: 8
Impact of Dyslipidemia on Tear Film and Meibomian Gland Dysfunction: A Cross-Sectional Study of the Interplay between Serum Lipid Profile and Ocular Surface Health
José-Manuel Serrano-Morales, Noelia Álvarez-Santaliestra, María Carmen Sánchez‐González, et al.
Journal of Ophthalmology (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 1
Total cholesterol to high-density lipoprotein cholesterol ratio is independently associated with CKD progression
Wei Li, Du Zhijie, Honglan Wei, et al.
International Urology and Nephrology (2022) Vol. 54, Iss. 8, pp. 2057-2063
Closed Access | Times Cited: 7
Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway
Yicen Zhou, Qijing Wu, Zhenfang Du, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 7
Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease
Paola Mogna-Peláez, Ana Romo‐Hualde, José Ignacio Riezu‐Boj, et al.
Journal of Physiology and Biochemistry (2023)
Open Access | Times Cited: 4
High-density lipoprotein protects vascular endothelial cells from indoxyl sulfate insults through its antioxidant ability
Ching Chen, Chia‐Chi Chang, I‐Ta Lee, et al.
Cell Cycle (2023) Vol. 22, Iss. 21-22, pp. 2409-2423
Closed Access | Times Cited: 4
Effects of Multiple‐Dose Administration of Aprocitentan on the Pharmacokinetics of Rosuvastatin
Patricia N. Sidharta, Jasper Dingemanse
Clinical Pharmacology in Drug Development (2020) Vol. 9, Iss. 8, pp. 995-1002
Closed Access | Times Cited: 11
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
Monique de Fátima Mello Santana, Aécio LA Lira, Raphael Pinto, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Association of High-Density Lipoprotein Cholesterol With GFR Decline in a General Nondiabetic Population
Toralf Melsom, Jon Viljar Norvik, Inger Therese Enoksen, et al.
Kidney International Reports (2021) Vol. 6, Iss. 8, pp. 2084-2094
Open Access | Times Cited: 9
Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis
Christina Charles‐Schoeman, Jennifer Wang, Ani Shahbazian, et al.
Rheumatology International (2023) Vol. 43, Iss. 6, pp. 1041-1053
Open Access | Times Cited: 3
Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism
Wen Dai, Mark Castleberry, Ze Zheng
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 10, pp. 2679-2696
Closed Access | Times Cited: 3
Effect of Selenium Supplementation on Lipid Profile, Anemia, and Inflammation Indices in Hemodialysis Patients
Samaneh Assarzadeh, Sahar Vahdat, Shiva Seirafian, et al.
Journal of Research in Pharmacy Practice (2022) Vol. 11, Iss. 3, pp. 103-108
Open Access | Times Cited: 4
Apoliprotein C-III (Apo C-III) inhibitors effect of antisense oligonucleotides in the management of dyslipidemia
I Gede Aswin Parisya Sasmana, Putu Nindya Krisnadewi Rahadi, Anggi Amanda Triana Devy, et al.
Indonesia Journal of Biomedical Science (2023) Vol. 17, Iss. 1, pp. 51-56
Open Access | Times Cited: 2
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease
Tarunveer S. Ahluwalia, Teemu Rönkkö, Mie K. Eickhoff, et al.
Kidney International Reports (2023) Vol. 9, Iss. 2, pp. 334-346
Open Access | Times Cited: 2
The Effects of Omega-3 Fatty Acids on Heart Diseases
Zekai Lyu
Highlights in Science Engineering and Technology (2023) Vol. 66, pp. 40-46
Closed Access | Times Cited: 2
A cohort study on risk factors of high-density lipoprotein cholesterol hypolipidemia among urban Chinese adults
Fang Tang, Jian Wang, Stephen Nicholas, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 5
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
Josep Julve, Joan Carles Escolà‐Gil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7488-7488
Open Access | Times Cited: 5
Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease
Anna Gliwińska, Agnieszka Ćwiklińska, Monika Czaplińska, et al.
Journal of Nephrology (2022) Vol. 36, Iss. 1, pp. 115-124
Open Access | Times Cited: 3
Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes
Maria F. Lopes‐Virella, Samar M. Hammad, Nathaniel L. Baker, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 190-190
Open Access
Exploration of the circulating human secretome through protein quantitative trait analysis identifies an association between circulating levels of apolipoprotein L1 and risk of giant cell arteritis
Natalie Chaddock, Michal Zulcinski, Javier Martı́n, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top